A panel of three immunohistochemical biomarkers was able to differentiate pancreatic cancer from surrounding normal tissue with 100% sensitivity, researchers have found.
Distinguishing benign lesions from hepatopancreaticobiliary malignancies is difficult. Cytology from endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound with fine needle aspiration (EUS-FNA) have been plagued by poor sensitivity and high rates of false-negative results, according to Atuhani S. Burnett,